Skip to main content
Caplight Logo









MedySapiens

MedySapiens

Private
SeoulHealthcare & Life Scienceshttps://medysapiens.com/en

Last Round

Series B

Jul 1, 2026

Total Funding Raised

$7M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

MedySapiens is a biotechnology company that develops AI-powered diagnostic solutions for the early detection of rare genetic diseases in newborns.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical AI, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

genomic data analysisrare disease diagnosisbioinformaticsneonatal diagnosticsclinical decision supportprecision medicinenext-generation sequencingNGSgenetic testinggenomics AImedical AIvariant interpretationclinical genomicsgenomic medicinedigital health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MedySapiens Comparables

Compare MedySapiens with similar companies based on industry and business-model similarity.

MedySapiens comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
enGenome
84%
Breakthrough Genomics
82%
SeqOne
78%

MedySapiens Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJul 1, 2026
Series AFeb 1, 2022
Pre SeedAug 27, 2019
SeedOct 26, 2018

Key People

Founding team and executive leadership

Taehyuk Kwon

COO

Executive Team

MedySapiens Investors

Notable investors and investment history

MedySapiens investors
InvestorRounds
L&S Venture CapitalSeries A
Vision CreatorSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 59% MoM, reaching 1.4K.

  • Jul 1, 2026

    Completed a Series B funding round.

MedySapiens Filings

Explore SEC and related filing metadata, where available.

MedySapiens filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about MedySapiens's valuation, stock price, and market status.

Is MedySapiens a public or private company?

MedySapiens is a private company.

What is the current stock price of MedySapiens?

MedySapiens is a private company with no public stock price. No recent secondary market data is available.

How much is MedySapiens worth (valuation)?

Valuation information for MedySapiens is not publicly available.

Can I buy MedySapiens stock?

MedySapiens shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was MedySapiens's last funding round?

MedySapiens's most recent funding round was Series B on July 1, 2026.

Who are the main investors in MedySapiens?

Key investors in MedySapiens include L&S Venture Capital, Vision Creator.

Will MedySapiens IPO soon?

No public IPO plans have been announced for MedySapiens.

How can I track MedySapiens secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor MedySapiens's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSeoul
Employee Range13
Year Founded2016
Last FundingJul 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?